As part of the $12m B round investment, Heath Lukatch and Tiba Aynechi, a partner and principal in Novo Ventures respectively, join Cianna's board.
Cianna Medical, a US-based medical device maker for treating breast cancer, has raised $12m in its series B round, two-thirds of which came from lead investor Novo Ventures, the corporate venturing unit of Denmark-based healthcare foundation Novo.
The B round money will be used to expand sales and marketing programs for Cianna’s Savi applicator.
As part of the investment, Heath Lukatch and Tiba Aynechi, a partner and principal in Novo Ventures respectively, join Cianna’s board.
Lukatch said: "Savi radiation…
